📌 Key Takeaways
- Topic: Spherical Silica Market 2026: Semiconductor Packaging Demand and Growth Outlook
- Keywords: silica carrier for pesticides
- Published: 2026-11-20 08:15:23
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Reinforcing Filler: How It Strengthens Rubber and Polymers
- Syloid Silica: Matting, Excipient and Food Grades Explained, with Alternatives
- Zhu, H. et al. Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy. Biomater. Adv. 144, 213229 (2023). Article CAS PubMed Google Scholar
- What Is the Formula for Silicon Dioxide? SiO₂ Explained
- Monocrystalline Silicon vs Silica: How Silicon Wafers Are Made from Quartz
- Silica as a Polishing Agent: How It Works and Where It Is Used
- Yu, J. et al. A novel application of nanohydroxyapatite/mesoporous silica biocomposite on treating dentin hypersensitivity: an in vitro study. J. Dent. 50, 21-29 (2016). Article CAS PubMed Google Scholar
What Is the Mohs Hardness of Silica and Quartz? Hardness Values Explained
What is silica (SiO₂)?
Wacker HDK Liu, Y. et al. Multifunctional Janus nanoplatform for efficiently synergistic theranostics of rheumatoid arthritis. ACS Nano 17, 8167-8182 (2023). Piece CAS PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
low alpha silica Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
What drives silica raw material prices?
Cab-O-Sil alternative Lei, J. et al. A bioactive nanocomposite sponge for simultaneous hemostasis and antimicrobial therapy. Nano Res. 16, 4004-4012 (2023). Article CAS Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.